Nuclear Receptor NR4A2 Orchestrates Th17 Cell-Mediated Autoimmune Inflammation via IL-21 Signalling

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Raveney, Ben J E ^a   Oki, Shinji ^a   Yamamura, Takashi ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 21; INTERLEUKIN 23 RECEPTOR; NUCLEAR RECEPTOR RELATED FACTOR 1; TRANSCRIPTION FACTOR FOXP3;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CELL POLARITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; EXPERIMENTAL AUTOIMMUNE UVEORETINITIS; FEMALE; IMMUNOMODULATION; IMMUNOREACTIVITY; IN VIVO STUDY; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TH17 CELL; UPREGULATION; UVEORETINITIS;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CELL DIFFERENTIATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INTERLEUKINS; MICE; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 2; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, HELPER-INDUCER; TH17 CELLS;

EID: 84874339517     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056595     Document Type: Article

References (52)

1. Sospedra M, Martin R, (2005) Immunology of multiple sclerosis. Annu Rev Immunol 23: 683-747.
2. Bettelli E, Korn T, Kuchroo VK, (2007) Th17: the third member of the effector T cell trilogy. Curr Opin Immunol 19: 652-657.
3. Damsker JM, Hansen AM, Caspi RR, (2010) Th1 and Th17 cells: adversaries and collaborators. Ann N Y Acad Sci 1183: 211-221.
4. Korn T, Oukka M, Kuchroo V, Bettelli E, (2007) Th17 cells: effector T cells with inflammatory properties. Semin Immunol 19: 362-371.
5. Goverman J, (2009) Autoimmune T cell responses in the central nervous system. Nat Rev Immunol 9: 393-407.
6. Jager A, Dardalhon V, Sobel RA, Bettelli E, Kuchroo VK, (2009) Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J Immunol 183: 7169-7177.
7. Luger D, Silver PB, Tang J, Cua D, Chen Z, et al. (2008) Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med 205: 799-810.
8. Steinman L, (2008) A rush to judgment on Th17. J Exp Med 205: 1517-1522.
9. Man S, Ubogu EE, Ransohoff RM, (2007) Inflammatory cell migration into the central nervous system: a few new twists on an old tale. Brain Pathol 17: 243-250.
10. Matusevicius D, Kivisakk P, He B, Kostulas N, Ozenci V, et al. (1999) Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult Scler 5: 101-104.
11. Hirota K, Duarte JH, Veldhoen M, Hornsby E, Li Y, et al. (2011) Fate mapping of IL-17-producing T cells in inflammatory responses. Nat Immunol 12: 255-263.
12. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, et al. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
13. Korn T, Bettelli E, Oukka M, Kuchroo VK, (2009) IL-17 and Th17 Cells. Annu Rev Immunol 27: 485-517.
14. Korn T, Bettelli E, Gao W, Awasthi A, Jager A, et al. (2007) IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 448: 484-487.
15. Das J, Ren G, Zhang L, Roberts AI, Zhao X, et al. (2009) Transforming growth factor beta is dispensable for the molecular orchestration of Th17 cell differentiation. J Exp Med 206: 2407-2416.
16. Ghoreschi K, Laurence A, Yang XP, Tato CM, McGeachy MJ, et al. (2011) Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling. Nature 467: 967-971.
17. Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, et al. (2003) Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421: 744-748.
18. McGeachy MJ, Cua DJ, (2007) The link between IL-23 and Th17 cell-mediated immune pathologies. Semin Immunol 19: 372-376.
19. Law SW, Conneely OM, DeMayo FJ, O'Malley BW, (1992) Identification of a new brain-specific transcription factor, NURR1. Mol Endocrinol 6: 2129-2135.
20. Perlmann T, Wallen-Mackenzie A, (2004) Nurr1, an orphan nuclear receptor with essential functions in developing dopamine cells. Cell Tissue Res 318: 45-52.
21. Le WD, Xu P, Jankovic J, Jiang H, Appel SH, et al. (2003) Mutations in NR4A2 associated with familial Parkinson disease. Nat Genet 33: 85-89.
22. Pearen MA, Muscat GE, (2010) Minireview: Nuclear Hormone Receptor 4A Signaling: Implications for Metabolic Disease. Mol Endocrinol 24: 1-13.
23. Aherne CM, McMorrow J, Kane D, FitzGerald O, Mix KS, et al. (2009) Identification of NR4A2 as a transcriptional activator of IL-8 expression in human inflammatory arthritis. Mol Immunol 46: 3345-3357.
24. O'Kane M, Markham T, McEvoy AN, Fearon U, Veale DJ, et al. (2008) Increased expression of the orphan nuclear receptor NURR1 in psoriasis and modulation following TNF-alpha inhibition. J Invest Dermatol 128: 300-310.
25. Saijo K, Winner B, Carson CT, Collier JG, Boyer L, et al. (2009) A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell 137: 47-59.
26. Satoh J, Nakanishi M, Koike F, Miyake S, Yamamoto T, et al. (2005) Microarray analysis identifies an aberrant expression of apoptosis and DNA damage-regulatory genes in multiple sclerosis. Neurobiol Dis 18: 537-550.
27. Doi Y, Oki S, Ozawa T, Hohjoh H, Miyake S, et al. (2008) Orphan nuclear receptor NR4A2 expressed in T cells from multiple sclerosis mediates production of inflammatory cytokines. Proc Natl Acad Sci U S A 105: 8381-8386.
28. Klemann C, Raveney BJ, Klemann AK, Ozawa T, von Horsten S, et al. (2009) Synthetic retinoid AM80 inhibits Th17 cells and ameliorates experimental autoimmune encephalomyelitis. Am J Pathol 174: 2234-2245.
29. Raveney BJ, Copland DA, Nicholson LB, Dick AD, (2008) Fingolimod (FTY720) as an acute rescue therapy for intraocular inflammatory disease. Arch Ophthalmol 126: 1390-1395.
30. Copland DA, Wertheim MS, Armitage WJ, Nicholson LB, Raveney BJ, et al. (2008) The clinical time-course of experimental autoimmune uveoretinitis using topical endoscopic fundal imaging with histologic and cellular infiltrate correlation. Invest Ophthalmol Vis Sci 49: 5458-5465.
31. Mensah-Brown EP, Shahin A, Al-Shamisi M, Wei X, Lukic ML, (2006) IL-23 leads to diabetes induction after subdiabetogenic treatment with multiple low doses of streptozotocin. Eur J Immunol 36: 216-223.
32. Fraser JM, Janicki CN, Raveney BJ, Morgan DJ, (2006) Abortive activation precedes functional deletion of CD8+ T cells following encounter with self-antigens expressed by resting B cells in vivo. Immunology 119: 126-133.
33. Raveney BJ, Copland DA, Dick AD, Nicholson LB, (2009) TNFR1-dependent regulation of myeloid cell function in experimental autoimmune uveoretinitis. J Immunol 183: 2321-2329.
34. Shao H, Liao T, Ke Y, Shi H, Kaplan HJ, et al. (2006) Severe chronic experimental autoimmune uveitis (EAU) of the C57BL/6 mouse induced by adoptive transfer of IRBP1-20-specific T cells. Exp Eye Res 82: 323-331.
35. Elias D, Prigozin H, Polak N, Rapoport M, Lohse AW, et al. (1994) Autoimmune diabetes induced by the beta-cell toxin STZ. Immunity to the 60-kDa heat shock protein and to insulin. Diabetes 43: 992-998.
36. Zhou L, Lopes JE, Chong MM, Ivanov, II, Min R, et al. (2008) TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 453: 236-240.
37. Sekiya T, Kashiwagi I, Inoue N, Morita R, Hori S, et al. (2011) The nuclear orphan receptor Nr4a2 induces Foxp3 and regulates differentiation of CD4+ T cells. Nat Commun 2: 269.
38. Zhou L, Ivanov, II, Spolski R, Min R, Shenderov K, et al. (2007) IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 8: 967-974.
39. Nurieva R, Yang XO, Martinez G, Zhang Y, Panopoulos AD, et al. (2007) Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448: 480-483.
40. Ivanov, II, Zhou L, Littman DR, (2007) Transcriptional regulation of Th17 cell differentiation. Semin Immunol 19: 409-417.
41. Bauquet AT, Jin H, Paterson AM, Mitsdoerffer M, Ho IC, et al. (2009) The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells. Nat Immunol 10: 167-175.
42. Veldhoen M, Hirota K, Westendorf AM, Buer J, Dumoutier L, et al. (2008) The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 453: 106-109.
43. Takeshita F, Minakuchi Y, Nagahara S, Honma K, Sasaki H, et al. (2005) Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo. Proc Natl Acad Sci U S A 102: 12177-12182.
44. Hueber W, Patel DD, Dryja T, Wright AM, Koroleva I, et al. (2011) Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci Transl Med 2: 52ra72.
45. Hofstetter HH, Ibrahim SM, Koczan D, Kruse N, Weishaupt A, et al. (2005) Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis. Cell Immunol 237: 123-130.
46. Komiyama Y, Nakae S, Matsuki T, Nambu A, Ishigame H, et al. (2006) IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 177: 566-573.
47. Monteleone G, Monteleone I, Fina D, Vavassori P, Del Vecchio Blanco G, et al. (2005) Interleukin-21 enhances T-helper cell type I signaling and interferon-gamma production in Crohn's disease. Gastroenterology 128: 687-694.
48. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, et al. (2005) IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201: 233-240.
49. Leonard WJ, Spolski R, (2005) Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation. Nat Rev Immunol 5: 688-698.
50. Vollmer TL, Liu R, Price M, Rhodes S, La Cava A, et al. (2005) Differential effects of IL-21 during initiation and progression of autoimmunity against neuroantigen. J Immunol 174: 2696-2701.
51. Coquet JM, Chakravarti S, Smyth MJ, Godfrey DI, (2008) Cutting edge: IL-21 is not essential for Th17 differentiation or experimental autoimmune encephalomyelitis. J Immunol 180: 7097-7101.
52. Sonderegger I, Kisielow J, Meier R, King C, Kopf M, (2008) IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo. Eur J Immunol 38: 1833-1838.